ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
131.586,45
-0,43%
S&P 500
5.722,26
-0,19%
US Dollar vs BRL
5,4751
0,00%
Bitcoin
63.383,46
0,40%
Brent Oil
72,845
-0,47%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Insulet Corporation (PODD)

  7. Insulet Corporation (PODD) Notícias

PODD

Insulet (PODD)

Insulet Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PODD
DataHoraFonteTítuloCódigoCompanhia
12/09/202417:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PODDInsulet Corporation
11/09/202416:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PODDInsulet Corporation
26/08/202417:20Business WireOmnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 DiabetesNASDAQ:PODDInsulet Corporation
20/08/202407:00Business WireInsulet to Present at Upcoming Investor ConferencesNASDAQ:PODDInsulet Corporation
14/08/202404:00Business WireInsulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in MalaysiaNASDAQ:PODDInsulet Corporation
09/08/202406:48IH Market NewsSweetgreen Rises 22% on Raised Forecasts, Doximity Jumps 30%, Rocket Lab Soars 14% on 71% Revenue Growth, and MoreNASDAQ:PODDInsulet Corporation
08/08/202417:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PODDInsulet Corporation
08/08/202417:01Business WireInsulet Reports Second Quarter 2024 Revenue Increase of 23% Year-Over-YearNASDAQ:PODDInsulet Corporation
26/07/202407:00Business WireInsulet Reports Preliminary Second Quarter 2024 Revenue ResultsNASDAQ:PODDInsulet Corporation
08/07/202407:00Business WireInsulet to Announce Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:PODDInsulet Corporation
21/06/202419:30Business WireInsulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 DiabetesNASDAQ:PODDInsulet Corporation
20/06/202407:05Business WireInsulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the NetherlandsNASDAQ:PODDInsulet Corporation
20/06/202407:00Business WireInsulet Announces Omnipod 5 Launch in France and U.S. Innovation UpdatesNASDAQ:PODDInsulet Corporation
28/05/202407:00Business WireInsulet to Present at the Jefferies Global Healthcare ConferenceNASDAQ:PODDInsulet Corporation
10/05/202408:58IH Market NewsJFrog and Akamai Drop Over 10% Despite Strong Profits; Sweetgreen, Array, SoundHound Surge, and More in EarningsNASDAQ:PODDInsulet Corporation
09/05/202417:01Business WireInsulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-YearNASDAQ:PODDInsulet Corporation
07/05/202407:00Business WireInsulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible GrowthNASDAQ:PODDInsulet Corporation
03/04/202407:00Business WireInsulet to Announce First Quarter 2024 Financial Results on May 9, 2024NASDAQ:PODDInsulet Corporation
20/03/202407:00Business WireInsulet Appoints Ana Maria Chadwick as Chief Financial OfficerNASDAQ:PODDInsulet Corporation
08/03/202408:00Business WireInsulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump TherapyNASDAQ:PODDInsulet Corporation
05/03/202408:00Business WireInsulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)NASDAQ:PODDInsulet Corporation
23/02/202410:03IH Market NewsGoldman Sachs Reconsiders Fed Cuts, LUNR Surges Over 40% in Pre-Market, and MoreNASDAQ:PODDInsulet Corporation
22/02/202418:07Business WireInsulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)NASDAQ:PODDInsulet Corporation
13/02/202418:01Business WireInsulet to Present at The Raymond James & Associates 45th Annual Institutional Investors ConferenceNASDAQ:PODDInsulet Corporation
09/02/202420:19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PODDInsulet Corporation
07/02/202408:00Business WireInsulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus SensorNASDAQ:PODDInsulet Corporation
22/01/202418:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PODDInsulet Corporation
18/01/202418:01Business WireInsulet Announces Changes to Board of Directors with Retirements and New AppointmentsNASDAQ:PODDInsulet Corporation
11/01/202408:00Business WireInsulet to Announce Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024NASDAQ:PODDInsulet Corporation
03/11/202308:32IH Market NewsFriday’s Wall Street Highlights: Apple, Bill Holdings, Paramount, Block, and moreNASDAQ:PODDInsulet Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:PODD

Seu Histórico Recente

TG
UQYG
BHP Billiton Finance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados